Intramuscular delivery of an AAV6 vector encoding a PspCas13b enzyme and DUX4-targeting guide RNAs reduced DUX4 mRNA by > 50% and improved histopathological outcomes in FSHD mice [49]. Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.